Диссертация на соискание ученой степени кандидата медицинских наук



жүктеу 1.82 Mb.
бет12/12
Дата10.09.2018
өлшемі1.82 Mb.
түріДиссертация
1   ...   4   5   6   7   8   9   10   11   12
et al. Sensitivity to cerebral ischemic insult in a rat model of stroke is determined by a single genetic locus // Nat Genet. – 1997. – 16. – Pp. 364-7

  • Jenny N.S., Tracy R.P., Ogg M.S., Luong le A., Kuller L.H., Arnold A.M., Sharrett A.R., Humphries S.E. In the elderly, interleukin6 plasma levels and the –174G>C polymorphism are associated with the development of cardiovascular disease // Arterioscler. Thromb. Vasc. Biol. – 2002. – 22. – Pp. 2066–2071

  • Jongeneel C. V.; Briant L.; Udalova I. A. et al. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes // Proc. Nat. Acad. Sci. – 1991. – 88. – Pp. 9717-9721

  • Jovanović D. R.Etiology of ischemic stroke among young adults of Serbia // Vojnosanit Pregl. – 2008. – Vol. 65, № 11. – Pp. 803 – 809

  • Kamali-Sarvestani E., Merat A., Talei A.R. Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer // Cancer Lett. – 2005. – 223. – Pp. 113–119

  • Karahan ZC, Deda G, Sipahi T, et al. TNF-alpha -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients // Thromb Res. – 2005. – 1155. – Pp. 393 -398

  • Katsuno, M., Yokota, H., Yamamoto, Y. & Teramoto, A. Increased regional interleukin-4 during the acute stage of severe intracranial disorders // Neurologia Medico-Chirurgica. – 2006. – 46. – Pp. 47

  • Kavvoura F. K., Akamizu T., Awata T., Ban Y., Chistiakov D. A., Frydecka I., Ghaderi A., Gough S. C., Hiromatsu Y., Ploski R., Wang P. W., Bednarczuk T., Chistiakova E. I., Chojm M., Heward J. M., Hiratani H., Juo S. H., Karabon L., Katayama S., Kurihara S., Liu R. T., Miyake I., Omrani G. H., Pawlak E., Taniyama M., Tozaki T., and Ioannidis J. P. Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis // J Clin Endocrinol Metab. – 2007. – 92(8). – Pp. 3162-3170

  • Khealani BA, Wasay M. The burden of stroke in Pakistan // Int J Stroke. – 2008. – Vol. 3, № 4. – Pp. 293 – 296

  • Khalangot M. et al. Gender Risk of Nonfatal Stroke in Type 2 Diabetic Patients Differs Depending on the Type of Treatment // J Womens Health. – 2008. – Pp. 23

  • Kiechl S., Reindl M., Wiedermann C.J. et al. Toll-like receptor 4 polymorphisms and atherogenesis // N Engl J Med. – 2002. – 347. – Pp. 185-192

  • Kim IY, Kim MM, Kim SJ. Transforming growth factor-beta : biology and clinical relevance // J Biochem Mol Biol. – 2005. – Jan 31;38(1). – Pp. 1-8

  • Kim JS. Cytokines and adhesion molecules in stroke and related diseases // J Neurol Sci. – 1996. – May;137(2). – Pp. 69-78

  • Kim MK, Kim JT, Choi SM, Lee SH, Park MS, Cho KH. Phosphodiesterase 4D gene and risk of noncardiogenic ischemic stroke in a Korean population // J Korean Med Sci. – 2009. – Apr;24(2). – Pp. 307-10

  • Kim OJ, Lee JH, Choi JK, Oh SH, Hong SH, Oh D, Kim NK. Association between tumor necrosis factor-alpha (-308G→A and -238G→A) polymorphisms and homocysteine levels in patients with ischemic strokes and silent brain infarctions // Cerebrovasc Dis. – 2010;30(5). – Pp. 483-90

  • Koenig W; Khuseyinova N. Biomarkers of Atherosclerotic Plaque Instability and Rupture // Arteriosclerosis, Thrombosis, and Vascular Biology. – 2007. – 27. – P.15

  • Kohsaka S., Volcik K., Folsom A.et al. Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G -765C polymorphism in African-Americans: The Atherosclerosis Risk in Communities Study // Atherosclerosis. – 2008. – 196. – Pp. 926–930

  • Kokubo Y., Chowdhury A.H., Date C., Yokoyama T., Sobue H., Tanaka H.: Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population.// Stroke. – 2000. – Jun;31(6). – Pp. 1299-306

  • Kokubo Y, Tomoike H, Tanaka C, Banno M, Okuda T, Inamoto N, Kamide K, Kawano Y, Miyata T. 13. Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate genes with blood pressure variation and hypertension // Hypertens Res. – 2006. – Aug;29(8). – Pp. 611-9

  • Kouki T., Y. Sawai C. Gardine M.-E. Fisfalen M.-L. Alegre L. J. DeGroot. 2000. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease // J. Immunol. – 165:6606

  • Kouwenhoven M., Carlstrom C., Ozenci V., Link H. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke // J Clin Immunol. – 2001. – Pp. 365–375

  • Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS // Trends Neurosci. – 1996. – V.19 №8. – Рp.312-8

  • Kristiansen OP, Nolsøe RL, Larsen L et al. Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females // Hum Mol Genet. – 2003. – May 153;12(10). – Pp. 1101-10

  • Kuhlenbäumer G, Berger K, Huge A, Lange E, Kessler C, John U, Funke H, Nabavi DG, Stögbauer F, Ringelstein EB, Stoll M. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort // J Neurol Neurosurg Psychiatry. – 2006. – Apr;77(4). – Pp. 521-4

  • Kurth T. et al. Lipid levels and the risk of ischemic stroke in women // In: Neurology. – 2007. – 68. – Pp. 556-562

  • Labreuche J., Touboul P. J., Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: A systematic review of the epidemiological studies // Atherosclerosis. – 2008. – № 10

  • Lafon M., Megret F., Lafage M. The innate immune facet of brain // Journal of Molecular Neuroscience. – 2006. – 29(3). – Pp. 185-194

  • Lai J, Zhou D, Xia S, Shang Y, Zhu J, Pan J, Hua B, Zhu Y, Cui L. Association of interleukin-1 gene cluster polymorphisms with ischemic stroke in a Chinese population // Neurol India. – 2006. – Dec;54(4). – Pp. 366-9

  • Lalouschek W, Endler G, Schillinger M, Hsieh K, Lang W, Cheng S, Bauer P, Wagner O, Mannhalter C. Candidate genetic risk factors of stroke: results of a multilocus genotyping assay // Clin Chem. – 2007. – 53. – Pp. 600–605

  • Lalouschek W., Schillinger M., Hsieh K., Endler G., Greisenegger S., Marculescu R., Lang W., Wagner O., Cheng S., Mannhalter C. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events //Clin. Chem. Lab. Med. – 2006. – 44. – Pp. 918–923

  • Lambertsen KL, Gregersen R, Meldgaard M, Clausen BH, Heibøl EK, Ladeby R, Knudsen J, Frandsen A, Owens T, Finsen B. A role for interferon-gamma in focal cerebral ischemia in mice // J Neuropathol Exp Neurol. – 2004. – Sep;63(9). – Pp. 942-55

  • Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response // FASEB J. – 2004. – May;18(7). – Pp. 816-27

  • Le Beau, M. M., Lemons, R. S., Espinosa 3rd, R., Larson, R. A., Arai, N., & Rowley, J. D. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q) // Blood. – 1989. – 73. – Pp. 647–650

  • Leppala J. M. et al. Different risk factors for different stroke subtypes // Stroke. – 1999. – Vol. 30. – Pp. 2535 – 2540

  • Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta // Annu Rev Immunol. – 1998. – V.16. – Рp.137-61

  • Leung T. W, Kwon S. U, Wong K. S. Management of patients with symptomatic intracranial atherosclerosis // Int J Stroke. – 2006. – Vol. 1. – № 1. – Pp. 20 – 25

  • Liao Y.C., Lin H.F., Guo Y.C., Yu M.L., Liu C.K., Juo S.H. Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis // BMC Med Genet. – 2010. – Jun 12;11. – P. 93

  • Libby P. Current concepts of the pathogenesis of the acute coronary syndromes // Circulation. – 2001. – Jul 17;104(3). – Pp. 365-72

  • Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis // Circulation. – 2002. – 105. – Pp. 1135–1143

  • Ligers A., Xu C., Saarinen S., Hillert J., and Olerup O., The CTLA-4 gene is associated with multiple sclerosis // J Neuroimmunol. – 1999. – 97(1-2). – Pp. 182-90

  • Linde R., Laursen H., Hansen A.J. Is Calcium Accumulation Post-Injury an Indicator of Cell Damage // Mechanisms of Secondary Brain Gamage in Cerebral Ischemia and Trauma. Springer Wien NY Acta Neurochir. – 1996. – 66. – Pp. 15-20

  • Lin H., Rathmell J.C., Gray G.S., Thompson C.B., Leiden J.M., Alegre M.L. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28 //J Exp Med. – 1998. – Jul 6;188(1). – Pp. 199-204

  • Li N., He Z., Xu J., Liu F., Deng S., Zhang H. Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population // Brain Res Bull. – 2010. – Jan 15;81(1). – Pp. 38-42

  • Lin R.T., Chen C.H., Tsai P.C., Ho B.L., Juo S.H., Lin H.F. Sex-specific effect of matrix metalloproteinase-9 functional promoter polymorphism on carotid artery stiffness // Atherosclerosis. – 2012. – Aug;223(2). – Pp. 416-20

  • Lio D, Marino V, Serauto A, Gioia V, Scola L, Crivello A, Forte GI, Colonna-Romano G, Candore G, Caruso C. Genotype frequencies of the +874T-->A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis // Eur J Immunogenet. – 2002. – Oct;29(5). – Pp. 371-4

  • Liu H., Maurice D.H. Phosphorylation meditated activation and translocation of the cyclic AMP specific phosphodiesterase PDE4D3 by cyclic AMP dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting // J. Biol. Chem. – 1999. – V. 274. № 15. – Pp. 10557–10565

  • Liu Y, Herrington D, Burdon KP, Langefeld CD, Rich SS, Bowden DW, Freedman BI, Wagenknecht LE. A functional polymorphism in the lymphotoxin-alpha gene is associated with carotid artery wall thickness: the Diabetes Heart Study // Eur J Cardiovasc Prev Rehabil. – 2006. – Aug;13(4). – Pp. 655-7

  • Lo J. C.; Wang, Y.; Tumanov, A. V. et al. Lymphotoxin beta receptor-dependent control of lipid homeostasis // Science. – 2007. – 316. – Pp. 285-288

  • Lohmussaar E., Gschwendtner A., Mueller J. C. ALOX5AP gene and PDE4D gene in a central European population of stroke patients // Stroke. – 2005. – 36. – Pp. 731—736

  • Lonneke M. L. De Lau1, Frank W. G. Leebeek, Moniek P. M. De Maat, Peter J. Koudstaal, Diederik W. J. Dippel. Reviews: A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke // Int J Stroke. – 2010. – Oct;5(5). – Pp. 385-94

  • Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schröder W, Herrmann FH, Jedrzejowska H. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke // Clin Appl Thromb Hemost. – 2001. – 7. – Pp. 346–350

  • Loppnow H., Zhang L., Buerke M., Lautenschläger M., Chen L., Frister A., Schlitt A., Luther T., Song N., Hofmann B., Rose-John S., Silber R.E., Müller-Werdan U., Werdan K. Statins potently reduce the cytokine-mediated IL-6 release in SMC // MNC cocultures. J Cell Mol Med. – 2010. – 15

  • Lovett-Racke, A.E., Smith, M.E., Arredondo, L.R., Bittner, P.S., Ratts, R.B., Shive, C.L., Forsthuber, T.G. & Racke, M.K. Developmentally regulated gene expression of Th2 cytokines in the brain // Brain Research. – 2000. – 870. – P.27

  • Lövkvist H, Smith JG, Luthman H, Höglund P, Norrving B, Kristoffersson U, Jönsson AC, Lindgren AG. Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region // Eur J Hum Genet. – 2008. – Sep;16(9). – Pp. 1117-25

  • Lusis A.J. Atherosclerosis // Nature. – 2000. – V. 407. – №68. – Pp. 233–241

  • Lussier Cacan S., Bolduc A., Xhignesse M. et al. Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype // Arterioscl. Thromb. Vasc. Biol. — 2002. — 22. — Pp. 824–831

  • Lvovs D., Favorova O.O., Favorov A.V. A Polygenic Approach to the Study 
of Polygenic Diseases // Acta Naturae. – 2012. – Jul;4(3). – Pp. 59-71

  • Macko RF, Ameriso SF, Gruber A, Griffin JH, Fernandez JA, Barndt R, Quismorio FP Jr, Weiner JM, Fisher M. Impairments of the protein C system and fibrinolysis in infection-associated stroke // Stroke. – 1996. – Nov;27(11). – Pp. 2005-11

  • Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, Scott R, Whyte S, Attia J. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding // J Stroke Cerebrovasc Dis. – 2011. – Mar-Apr;20(2). – Pp. 134-44

  • Mangan D.F., Robertson B., Wahl S.M. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes // J Immunol. – 1992. – V.148, №6. – Рp.1812-6

  • Manji HK, McNamara R, Chen G, Lenox RH. Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness // Aust N Z J Psychiatry. – 1999. – 33. – Pp. 65–83

  • Markus H.S. Stroke genetics // Hum Mol Genet. – 2011. – Oct 15;20(R2). – Pp. 124-31

  • Markoula S., Giannopoulos S., Kostoulas C., Tatsioni A., Bouba I., Maranis S., Georgiou I., Kyritsis A.P. Gender association of the angiotensin-converting enzyme gene with ischaemic stroke // J Renin Angiotensin Aldosterone Syst. – 2011. – Dec;12(4). – Pp. 510-5

  • Marousi S, Antonacopoulou A, Kalofonos H, Papathanasopoulos P, Karakantza M, Ellul J. Functional inflammatory genotypes in ischemic stroke: could we use them to predict age of onset and long-term outcome? // Stroke Res Treat. – 2011. – Pp.792-923

  • Marousi S, Ellul J, Antonacopoulou A, Gogos C, Papathanasopoulos P, Karakantza M. Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke // Eur J Neurol. – 2011. – Apr;18(4). – Pp. 637-43

  • Marron M.P., Raffel L.J., Garchon H.J., Jacob C.O., Serrano-Rios M., Martinez Larrad M.T., Teng W.P., Park Y., Zhang Z.X., Goldstein D.R., Tao Y.W., Beaurain G., Bach J.F., Huang H.S., Luo D.F., Zeidler A., Rotter J.I., Yang M.C., Modilevsky T., Maclaren N.K., She J.X. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups // Hum Mol Genet. – 1997. – V.6, №8. – Рp.1275-82

  • Marsh D.G., Neely J.D., Breazeale D.R., Ghosh B., Freidhoff L.R., Ehrlich-Kautzky E., Schou C., Krishnaswamy G., Beaty T.H. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations // Science. – 1994. – V.264, №5162. – Рp.1152-6

  • Matarín M.A. Genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release // Lancet Neurol. – 2007. – May;6(5). – Pp. 414-20

  • Matsushita T, Kubo M, Yonemoto K, Ninomiya T, Ashikawa K, Liang B, Hata J, Doi Y, Kitazono T, Ibayashi S, Iida M, Kiyohara Y, Nakamura Y. Lack of association between variations of PDE4D and ischemic stroke in the Japanese population // Stroke. – 2009. – Apr;40(4). – Pp. 1245-51

  • Matsushita T, Umeno J, Hirakawa Y, Yonemoto K, Ashikawa K, Amitani H, Ninomiya T, Hata J, Doi Y, Kitazono T. et al. Association study of the polymorphisms on chromosome 12p13 with atherothrombotic stroke in the Japanese population // J Hum Genet. – 2010. – 55. – Pp. 473–476

  • McAdam A. J., Schweitzer A. N., Sharpe A. H.. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells // Immunol Rev. – 1998. – 165. – Pp. 231-247

  • McColl B.W., Allan S.M., Rothwell N.J. Systemic infection, inflammation and acute ischemic stroke // Neuroscience. – 2009. – 158. – Pp. 1049–1061

  • Mehrotra PT, Donnelly RP, Wong S, Kanegane H, Geremew A, Mostowski HS, Furuke K, Siegel JP, Bloom ET. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12 // J Immunol. – 1998. – Mar 15;160(6). – Pp. 2637-44

  • Meschia J. F., Brott T. G., Brown R. D., Jr. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke // Ann. Neurol. – 2005. – 58. – Pp. 351—361

  • Meschia J. F., Brown R. D., Brott T. G., Hardy J., Atkinson E. J., and O’Brien P. C. Feasibility of an affected sibling pair study in ischemic stroke: results of a 2-center family history registry // Stroke. – 2001. – Vol. 32, № 12. – Pp. 2939–2941

  • Meschia JF, Singleton A, Nalls MA, Rich SS, Sharma P, Ferrucci L, Matarin M, Hernandez DG, Pearce K, Brott TG, Brown RD Jr, Hardy J, Worrall BB. Genomic risk profiling of ischemic stroke: results of an international genome-wide association meta-analysis // PLoS One. – 2011. – 6(9)

  • Messer G., Spengler U., Jung M.C., Honold G., Blomer K., Pape G.R. et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-b gene correlates with a variant amino acid in position 26 and reduced level of TNF-b production // J Exp Med. – 1991. – 173. – Pp. 209–219

  • Milton AG, Aykanat VM, Hamilton-Bruce MA, Nezic M, Jannes J, Koblar SA. Association of the phosphodiesterase 4D (PDE4D) gene and cardioembolic stroke in an Australian cohort // Int J Stroke. – 2011. – Dec;6(6). – Pp. 480-6

  • Miossec P., & van den Berg W. Th1/Th2 cytokine balance in arthritis // Arthritis and Rheumatism. – 1997. – 40. – Pp. 2105–2115

  • Monraats PS, Pires NMM, Schepers A, Agema W, Boesten L, Vries M, Zwinderman A, de Maat M, Doevendans P, Winter R, Tio R, Waltenberger J, Hart L, Frants R, Quax P, Vlijmen B, Havekes L, Laarse A, Wall E, Jukema W. Tumor necrosis factor- α plays and important role in restenosis development // The FASEB J. – 2005. – 19. – Pp. 1998–2004

  • Mooijaart SP, Berbee JF, van Heemst D et al: ApoE plasma levels and risk of cardiovascular mortality in old age // PLoS Med. – 2006. – 3. – e176

  • Morisaki N., Saito I., Tamura K., Tashiro J., Masuda M., Kanzaki T., et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease // Atherosclerosis. – 1997. – 131. – Pp. 43–48

  • Morrison AC, Ballantyne CM, Bray M, Chambless LE, Sharrett AR, Boerwinkle E. LPL polymorphism predicts stroke risk in men // Genet Epidemiol. – 2002. – Mar;22(3). – Pp. 233-42

  • Morita A, Nakayama T, Soma M. Association study betweenC-reactive protein genes and ischemic stroke in Japanese subjects //Am J Hypertens. – 2006. – 19. – Pp. 593–600

  • Munshi A., Babu M.S., Kaul S. et al. Phosphodiesterase 4D (PDE4D) gene variants and the risk of ischemic stroke in a South Indian population // J. Neurol. Sci. — 2009. — Vol. 285, № 1–2. — Pp. 142–145

  • Munshi A., Kaul S. Stroke genetics – focus on PDE4D gene // Int. J. Stroke. – 2008. – V. 3. № 3. Pp. 188–192

  • Munshi A, Roy S, Thangaraj K, Kaul S, Babu MS, Jyothy A. Association of SNP41, SNP56 and a novel SNP in PDE4D gene with stroke and its subtypes // Gene. – 2012. – Sep 10;506(1). – Pp. 31-5.

  • Myllykangas L, Polvikoski T, Sulkava R, Notkola IL, Rastas S, Verkkoniemi A, Tienari PJ, Niinistö L, Hardy J, Pérez-Tur J, Kontula K, Haltia M. Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study // Ann Med. – 2001. – Oct;33(7). – Pp. 486-92

  • My-Young Cheong, Ok-Sun Bang, Min-Ho Cha, Young-Kyu Park, Seung-Ho Kim, and Young Joo Kim. Association of the Adiponectin Gene Variations with Risk of Ischemic Stroke in a Korean Population // Yonsei Med J. – 2011. – 52(1). – Pp. 20-25

  • Napolioni V, Lucarini N. Gender-specific association of ADA genetic polymorphism with human longevity // Biogerontology. – 2010. – Aug;11(4). – Pp. 457-62

  • Nedwin G. E., Naylor S. L., Sakaguchi A. Y., Smith D., Jarrett-Nedwin J., Pennica D., Goeddel D. V., and Gray P. W., Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization // Nucleic Acids Res. – 1985. – 13(17). – Pp. 6361-73

  • Nisticò L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., Larrad M.T., Rios M.S., Chow C.C., Cockram C.S., Jacobs K., Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry // Hum Mol Genet. – 1996. – Jul;5(7). – Pp. 1075-80

  • Nofer J.R. Estrogens and atherosclerosis: insights from animal models and cell systems // J Mol Endocrinol. – 2012. – 48. – Pp. 13-29

  • Nordström P., Glader C.A., Dahlén G., Birgander L.S., Lorentzon R., Waldenström A., Lorentzon M. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women // J Intern Med. – 2003. – Aug;254(2). – Pp. 140-6

  • O’Brien K. D., McDonald T. O., Chait A., Allen M. D., and Alpers C. E. Neovascular expression of Eselectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content // Circulation. – 1996. – 93. – Pp. 672–682

  • Oda K., Tanaka N., Arai T., Araki J, Song Y, Zhang L, Kuchiba A, Hosoi T, Shirasawa T, Muramatsu M, Sawabe M. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases // Hum Mol Genet. – 2007. – Mar 15;16(6). – Pp.592-9

  • Orlacchio A, Bernardi G.: Research actuality in the genetics of stroke. // Clin Exp Hypertens. – 2006. – Apr-May;28(3-4). – Pp. 191-7

  • Orlinick J.R. and Chao, M.V. TNF-related ligands and their receptors // Cell Signal. – 1998. – 10. – Pp. 543-551

  • Oshima T., Laroux F. S., Coe L. L., Morise Z., Kawachi S., Bauer P., Grisham M. B., Specian R. D., Carter P., Jennings S., Granger D. N., Joh T., and Alexander J. S., Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function // Microvasc Res. – 2001. – 61(1). – Pp. 130-43

  • Ostrov D.A., Shi W., Schwartz J.C., Almo S.C., Nathenson S.G. Structure of murine CTLA-4 and its role in modulating T cell responsiveness // Science. – 2000. – Oct 27;290(5492). – Pp. 816-9

  • Ozaki K.; Ohnishi, Y.; Iida, A. et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction // Nature Genet. – 2002. – 32. – Pp. 650-654

  • Pablos Mendez A., Mayeux R., Ngai C. et al. Association of apo E polymorphism with plasma lipid levels in multiethnic elderly population // Arterioscl. Thromb. Vasc. Biol. – 1997. – 17. – Pp. 3534–3541

  • Pan X., Arauz E., Krzanowski J.J. et al. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells // Biochem. Pharmacol. – 1994. – V. 48. № 4. – Pp. 827–836

  • Parfenov MG, Nikolaeva TY, Sudomoina MA, Fedorova SA, Guekht AB, Gusev EI, Favorova OO. Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity // J Neurol Sci. – 2007. – Apr 15;255(1-2). – Pp. 42-9

  • Peng Z, Zhan L, Chen S, Xu E. Association of transforming growth factor-β1 gene C-509T and T869C polymorphisms with atherosclerotic cerebral infarction in the Chinese: a case-control study // Lipids Health Dis. – 2011. – Jun 16;10. – P. 100

  • Perlstein TS, Lee RT: Smoking, metalloproteinases, and vascular disease // Arterioscler Thromb Vasc Biol. – 2006. – 26. – Pp. 250-6

  • Petty G. W. et al. Survival and recurrence after first cerebral infarction: a population-based study in Rochester // Neurology. – 1998. – Vol. 50. – Pp. 208 – 216

  • Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Dalla Volta G, Archetti S, Zavarise P, Camarda C, Gasparotti R, Magoni M, Camarada R, Padovani A. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect // Stroke. – 2007. – 38. – Pp. 3145–3151

  • Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P. Synergisticeffect of 174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1gene in Italian patients with history of ischemic stroke // Stroke. – 2003. – 34. – Pp. 881–5

  • Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P. J., and Hutchinson I. V., In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene // Eur J Immunogenet. – 1999. – 26(1). – Pp. 1-3

  • Pravica V., Perrey C., Stevens A., Lee J. H., and Hutchinson I. V., A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production // Hum Immunol. – 2000. – 61(9). – Pp. 863-6

  • Prehn J.H.M, Bindokas V.P., Marcuccilli C.J..et al. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons //Proc Nat Acad Sc. USA – 1994. – 91. – Pp. 12599-12603

  • Pruissen DM, Rosendaal FR, Frijns CJM, Kappelle LJ, Vos HL, Algra A; Smart Study Group. Prothrombotic gene variation and new vascular events after cerebral ischemia of arterial origin // J Thromb Haemost. – 2008. – 6. – Pp. 1639−1644

  • Rattazzi M., Puato M., Faggin E. et al. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens 2003;21(10):1787–803

  • Razvi SS, Bone I.: Single gene disorders causing ischaemic stroke. //J Neurol. – 2006. – Jun 253(6). – Pp. 685-700

  • Reich K., Mossner R., Konig I.R., G. Westphal, A. Ziegler, C. Neumann Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset // J Investig Dermatol. – 2002. – 118. – Pp. 155–163

  • Renzhe Cui, MD; Hiroyasu Iso, MD; Kazumasa Yamagishi, MD; Isao Saito, MD; Yoshihiro Kokubo, MD; Manami Inoue, MD; Shoichiro Tsugane, MD. Diabetes Mellitus and Risk of Stroke and Its Subtypes Among Japanese // Stroke. – 2011. – Sep;42(9). – Pp. 2611-4

  • Ring C.J., Cho K.W. Specificity in transforming growth factor-beta signaling pathways // Am J Hum Genet. – 1999. – V.64, №3. – Рp.691-7

  • Richards A., van den Maagdenberg A.M., Jen J.C., Kavanagh D. Bertram P., Spitzer D., Liszewski M.K., Barilla-Labarca M.L.,Terwindt G.M., Kasai Y. et al. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy // Nat. Genet. – 2007. – 39. –Pp. 1068–1070

  • Rincon F, Sacco R. L. Secondary stroke prevention // J Cardiovasc Nurs. – 2008. – Vol. 23, № 1. – Pp. 34 – 41

  • Roach D.R., Briscoe, H., Saunders, В., France, M.P., Riminton, S., and Britton, W.J. Secreted Lymphotoxin-alpha Is Essential for the Control of an Intracellular Bacterial Infection // J Exp Med. – 2001. – 193. – Pp. 239-246

  • Roest M. et al. Risk of acute ischemic heart disease in postmenopausal women depends on von Willebrand factor and fibrinogen concentrations, and blood group genotype // In: J Thromb Haemost. – 2007. – 5(1). – Pp. 189-191

  • Romagnani S. Regulation of the T cell response // Clin Exp Allergy. – 2006. – V.36, №11. – Рp.1357-66

  • Rose-John S., Scheller J., Elson G., Jones S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer // J Leukoc Biol. – 2006. – 80(2). – Pp. 227–36

  • Rosenwasser L.J., Borish L. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10) // Am J Respir Crit Care Med. – 1997. – V.156, №4, Pt 2. – Рp. 152-5

  • Rosenwasser L.J., Borish L. Promoter polymorphisms predisposing to the development of asthma and atopy // Clin Exp Allergy. – 1998. – 28 (Suppl 5). – Pp. 13–15

  • Rosenwasser L.J., Klemm D.J., Dresback J.K., Inamura H., Mascali J.J., Klinnert M., Borish L. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy // Clin Exp Allergy. – 1995. – V.25, Suppl 2. – Рp.74-8; discussion 95-6

  • Ross R.Cell biology of atherosclerosis // Annu Rev Physiol. – 1995. – 57. – Pp. 791-804

  • Rost NS, Rahman RM, Biffi A, Smith EE, Kanakis A, Fitzpatrick K, Lima F, Worrall BB, Meschia JF, Brown RD Jr, Brott TG, Sorensen AG, Greenberg SM, Furie KL, Rosand J. White matter hyperintensity volume is increased in small vessel stroke subtypes // Neurology. – 2010. – Nov 9;75(19). – Pp. 1670-7

  • Rothwell P.M. Carotid artery disease and the risk of ischaemic stroke and coronary vascular events // Cerebrovasc Dis. – 2000. – 10. – Pp. 21–33

  • Rothwell PM, Howard SC, Power DA, et al. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke // Stroke. – 2004. – 35. – Pp. 2300-5

  • Rubattu S, Di Angelantonio E, Stanzione R, Zanda B, Evangelista A, Pirisi A, De Paolis P, Cota L, Brunetti E, Volpe M.: Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. //J Hypertens. – 2004. – Nov, 22(11). – Pp. 2129-34

  • Rubattu S, Lee-Kirsch MA, DePaolis P, Giliberti R, Gigante B, Lombardi A, Volpe M, Lindpaintner K.: Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat. //Circ Res. – 1999. – Nov 12;85(10). – Pp. 900-5

  • Rubattu S, Speranza R, Ferrari M, Evangelista A, Beccia M, Stanzione R, Assenza GE, Volpe M, Rasura M.: A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study. //Eur J Neurol. – 2005. – Dec;12(12). – Pp. 989-93

  • Rudofsky G., Jr., Schlotterer A., Reismann P., Engel J., Grafe I.A., Tafel J., Morcos M., Humpert P.M., Nawroth P., Bierhaus A., Hamann A. The -174G>C IL-6 gene promoter polymorphism and diabetic microvascular complications // Horm Metab Res. – 2009. – V.41, №4. – Рp.308-13

  • Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall // Atherosclerosis. – 1996. – 127. – Pp. 263–271

  • Ryglewicz D., Polarowska M., Lechewicz W. et al.: Stroke Mortality Rates in Poland Did Nat Decline Between 1984 and 1992 //Stroke. – 1997. – 28,4. – Pp. 752-757

  • Sacco R. L. et al. High-density lipoprotein cholesterol and ixchemic stroke in the elderly // JAMA. – 2001. – Vol. 285. – Pp. 2729 – 2735.

  • Sampanis C., Zamboulis C. Arterial hypertension in diabetes mellitus: from theory to clinical practice // Hippocratia. – 2008. – Vol. 12, № 2. – Pp. 74 – 80

  • Saito T, Tamura K, Uchida D, Saito T, Nitta T, Sugisaki Y. Histopathological evaluation of left atrial appendage thrombogenesis removed during surgery for atrial fibrillation // Am Heart J. – 2007. – Apr;153(4). – Pp. 704-11

  • Sambrook J., Fritsch E. F., Maniatis T.: Molecular Cloning // ed Nolan, C. Cold Spring Harbor Press. – 1989. 9.17-9.19

  • Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I. Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C // Brain Res Bull. – 2006. – Dec 11;71(1-3). – Pp. 45-50

  • Scarabin PY, Arveiler D, Amouyel P, Dos Santos C, Evans A, Luc G, Ferrieres J, Juhan-Vague I. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study // Atherosclerosis. – 2003. – 166. – Pp. 103-109

  • Seifart C., Plagens A., Dempfle A., Clostermann U., Vogelmeier C., von Wichert P., Seifart U. TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer // Dis Markers. – 2005. – V.21, №3. – Рp.157-65

  • Seino Y, Ikeda U, Ikeda M et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions // Cytokine. – 1994. – 6. – Pp. 87–91

  • Seripa D, Dobrina A, Margaglione M, Matera MG, Gravina C, Vecile E et al . Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke // Cerebrovasc Dis. – 2003. –15. – Pp. 276-81

  • Seshadri S, Beiser A, Pikula A, et al.: Parental occurrence of stroke and risk of stroke in their children: the Framingham study // Circulation. – 2010. – 121. – Pp. 1304–1312

  • Settin A., Zedan M., Farag M., Ezz El Regal M., Osman E. Gene polymorphisms of IL-6(-174) G/C and IL-1Ra VNTR in asthmatic children // Indian J Pediatr. – 2008. – V.75, №10. – Рp.1019-23

  • Schieffer B., Schieffer E., Hilfiker Kleiner D., Hilfiker A.,Kovanen P.T., Kaartinen M., Nussberger J.,HarringerW., Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability // Circulation. – 2000. – 101. – Pp. 1372–1378

  • Shen C, Jiao WW, Feng WX, Wu XR, Xiao J, Miao Q, Sun L, Wang BB, Wang J, Liu F, Shen D, Shen AD. IFNG polymorphisms are associated with tuberculosis in Han Chinese pediatric female population // Mol Biol Rep. – 2013. – Sep;40(9). – Pp. 5477-82.

  • Shenhar-Tsarfaty S, Assayag EB, Bova I, Shopin L, Berliner S, Shapira I, Bornstein NM. Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications // Thromb Res. – 2008. – 122(2). – Pp. 167-73

  • Shi C, Kang X, Wang Y, Zhou Y. The coagulation factor V Leiden, MTHFRC677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke //Clin Chim Acta. – 2008. – Oct;396(1-2). – Pp. 7-9

  • Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M, Hamamoto M, Mizuno Y. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese // Stroke. – 2001. – 32. – Pp. 1481–1486

  • Sie MP, Uitterlinden AG, Bos MJ, Arp PP, Breteler MM, Koudstaal PJ, Pols HA, Hofman A, van Duijn CM, Witteman JC. TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study // Stroke. – 2006. – Nov;37(11). – Pp. 2667-71

  • Sing C. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation // Am J Hum Genet. – 1985. – Vol. 37. – Pp. 268 – 285

  • Slowik A, Iskra T, Turaj W, Hartwich J, Dembinska-Kiec A, Szczudlik A: LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease // J Neurol Sci. – 2003. – 214. – Pp. 11– 16

  • Smith B.M., Irving S., Sheldon J. et al. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable // Circulation. – 2001. – Vol. 104. – P. 746

  • Smith W.B., Noack L., Khew-Goodall Y. et al. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium // J. Immunol. – 1996. – 157(1). – Pp. 360-368

  • Solari V., Owen D., Puri P. Association of transforming growth factor-beta1 gene polymorphism with reflux nephropathy // J Urol. – 2005. – V.174, №4, Pt 2. – Рp.1609-11

  • Staton JM, Sayer MS, Hankey GJ, Attia J, Thakkinstian A, Yi Q, Cole VJ, Baker R, Eikelboom JW.: Association between phosphodiesterase 4D gene and ischaemic stroke. //J Neurol Neurosurg Psychiatry. – 2006. Sep 77(9). – Pp. 1067-9

  • Steiner I, Gotkine M, Wirguin I. The protective effect of risk factors against stroke severity // J Neurol Sci. – 2008. – 267. – Pp. 187–8

  • Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.// Stroke. – 2006. – Jul, 37(7). – Pp.1923-32

  • Sudlow C, Martinez Gonzalez NA, Kim J, Clark C: Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage. Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls // Stroke. – 2006. – 37. – Pp. 364– 370

  • Sun Y, Huang Y, Chen X, Liu Y, Lu X, Shi Y, Tang W, Yang J, Chen W, Zhao X, Gao L, Li S, Feng G, He L. Association between the PDE4D gene and ischaemic stroke in the Chinese Han population // Clin Sci (Lond). – 2009. –Aug 17,117(7). – Pp. 265-72

  • Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage // Proc Natl Acad Sci U S A. – 2000. – Mar 28,97(7). – Pp. 3479-84

  • Suzuki S., Tanaka K., Suzuki N. Ambivalent aspects of interleukin6 in cerebral ischemia: inflammatory versus neurotrophic aspects // J. Cerebral Blood Flow& Metabolism. – 2009. – 29. – Pp. 464–479

  • Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease // Clin Sci (Lond). – 1998. – Dec;95(6). – Pp. 659-67

  • Szolnoki Z, Havasi V, Talián G, Bene J, Komlósi K, Somogyvári F, Kondacs A, Szabó M, Fodor L, Bodor A, Melegh B. Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke // J Mol Neurosci. – 2005. – 27(2). – Pp. 205-11

  • Szolnoki Z., Maasz A., Magyari L., Horvatovich K., Farago B., Kondacs A., Bodor A, Hadarits F, Orosz P, Ille A, Melegh B. Galectin-2 3279TT variant protects against the lymphotoxin-alpha 252GG genotype associated ischaemic stroke // Clin Neurol Neurosurg. – 2009. – Apr, 111(3). – Pp. 227-30

  • Szpirer C., Szpirer J., Rivière M. et al. Chromosomal localization of the human and rat genes (PDE4D and PDE4B) encoding the cAMP specific phosphodiesterases 3 and 4 // Cytogenet. Cell Genet. – 1995. – V. 69, № 1–2. – Pp. 11–14

  • Takashima S., Hirano K., Taguchi Y., Dougu N., Toyoda S., Tanaka K. Two cases of cardioembolic stroke with stepwise progression // Rinsho Shinkeigaku. – 2008. – Sep, 48(9). – Pp. 656-61

  • Takahashi K., Takeya M., Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.// Med Electron Microsc. – 2002. – Dec, 35(4). – Pp.179-203

  • Tao H.M., Chen G.Z., Cheng G.P., Shan X.Y. The haplotype of the TGFβ1 gene associated with cerebral infarction in Chinese // Can J Neurol Sci. – 2012. – Sep, 39(5). – Pp. 626-31

  • Tao H.M., Chen G.Z., Lu X.D., Chen G.P., Shao B. TGF-β1 869T/C polymorphism and ischemic stroke: sex difference in Chinese // Can J Neurol Sci. – 2010. – Nov, 37(6). – Pp. 803-7

  • Tao H. M., Shao B., Chen G. Z. Meta-analysis of the ACE gene polymorphism in cerebral infarction // Can J Neurol Sci. – 2009. – Vol. 36, № 1. – Pp. 20 – 25

  • Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways // Physiol Rev. – 2006. – Apr, 86(2). – Pp. 515-81

  • Thabele M., Leslie-Mazwi, MD, Thomas G. Brott, MD, Robert D. Brown Jr, MD, Bradford B. Worrall, MD, Scott L. Silliman, MD, L. Douglas Case, PhD, Michael R. Frankel, MD, Stephen S. Rich, PhD, and James F. Meschia, MD. Sex Differences in Stroke Evaluations in the Ischemic Stroke Genetics Study // J Stroke Cerebrovasc Dis. – 2007. – 16(5). – Pp. 187–193

  • Tong Y, Geng Y, Xu J, Wang Z, Zhang Y, Lin L, Zhang R, Deng P, Li Y, Hou W, Chai Y, Mason KA, Lu Z, Cheng J. The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case-control studies // Clin Chim Acta. – 2010. – Sep 6, 411(17-18). – Pp. 1291-5

  • Tonk M. and Haan J. A review of genetic causes of ischemic and hemorrhagic stroke // Journal of the Neurological Sciences. – 2007. –Vol. 257, № 1-2. – Pp. 273–279,

  • Toni D., Sacchetti M. L., Prencipe M. Early Clinical Diagnosis of Lacunar Strokes // Stroke. – 2008. –Vol. 39. –Pp. 152

  • Trompet S, Pons D, DE Craen AJ, Slagboom P, Shepherd J, Blauw GJ, et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study // Ann NY Acad Sci. – 2007. – 1100. – Pp. 189–98

  • Tso A.R., Merino J.G., Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review // Stroke. – 2007. – 38. – Pp. 3070–3075

  • Tuomilehto J., Rastenyte D., Jousilahti F. Diabetes mellitus as a risk factors for death for stroke. Prospective study of the Middle-aged Finnish population // Stroke. – 1996. – Vol. 27. – Pp. 210 – 215

  • Uchiyama S. Cerebral infarction // Nippo Rinsho. – 2006. – Vol. 64, № 11. – P. 2039 – 2044

  • Ueda H., Howson J. M., Esposito L. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease // Nature. – 2003. – Vol. 423. – Pp. 506–511

  • Um JY, An NH, Kim HM. TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction // J Mol Neurosci. – 2003. – 21(2). – Pp. 167-71

  • Um JY, An NH, Kim SH, Lee KM, Kim YS, Jang H, Cho KH, Moon BS, Kim HM. Genetic susceptibility to ischemic cerebrovascular disease in Koreans // J Mol Neurosci. – 2003. Feb, 20(1). – Pp. 31-8

  • Um JY, Moon KS, Lee KM, Yun JM, Cho KH, Moon BS, Kim HM. Association of interleukin-1 alpha gene polymorphism with cerebral infarction // Brain Res Mol Brain Res. – 2003. –Jul 4, 115(1). –Pp. 50-4

  • Vallinoto AC, Graça ES, Araújo MS, Azevedo VN, Cayres-Vallinoto I, Machado LF, Ishak MO, Ishak R. IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis // Hum Immunol. – 2010. – Jul;71(7). – Pp. 692-6

  • Van Vliet P, Mooijaart SP, de Craen AJ, Rensen PC, van Heemst D, Westendorp RG: Plasma levels of apolipoprotein E and risk of stroke in old age // Ann NY Acad Sci. – 2007. – 1100. – Pp. 140– 147

  • Veglio F. et al. Hypertension and cerebrovascular damage // Atherosclerosis. – 2008. – № 5

  • Verstrepen L, Bekaert T, Chau TL et al. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme // Cell Mol Life Sci. – 2008. – Oct, 65(19). – Pp. 2964-2978

  • Vila-del Sol V, Punzón C, Fresno M. IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages // J Immunol. – 2008. – Oct 1,181(7). – Pp. 4461-4470

  • Vila N, Reverter JC, Yagüe J, Chamorro A. Interaction between interleukin-6 and the natural anticoagulant system in acute stroke // J Interferon Cytokine Res. – 2000. – Mar, 20(3). – Pp. 325-329

  • Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E.: P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study. //Atherosclerosis. – 2006. – May, 186(1). – Pp.74-79

  • Walston J.D., Fallin M.D., Cushman M., Lange L.,Psaty B., Jenny N., Browner W., Tracy R., Durda P.,Reiner A. IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the cardiovascular health study // Hum. Genet. – 2007. – 122. – Pp. 485–494

  • Wang Q, Ding H, Tang JR, Zhang L, Xu YJ, Yan JT, Wang W, Hui RT, Wang CY, Wang DW. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population // Acta Pharmacol Sin. – 2009. – Mar, 30(3). – Pp. 291-298

  • Wang X., Cheng S., Brophy V.H., Erlich H.A., Mannhalter C., Berger K., Lalouschek W., Browner W.S., Shi Y., Ringelstein E.B., Kessler C., Luedemann J., Lindpaintner K., Liu L., Ridker P.M., Zee R.Y., Cook N.R.; RMS Stroke SNP Consortium. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients //Stroke. – 2009. – Mar, 40(3). – Pp. 683-695

  • Wang X.L., Sim A.S., Wilcken D.E. A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease // Clin Sci (Lond). – 1998. – Dec, 95(6). – Pp. 745-746

  • Wang Y., Hou X., Li Y. Association between transforming growth factor beta1 polymorphisms and atrial fibrillation in essential hypertensive subjects // J Biomed Sci. – 2010. – Mar 31, 17. – Pp. 23

  • Wei-Chieh Weng , Wen-Yi Huang , Yu-Yi Chien , Chia-Lun Wu , Feng-Chieh Su , Heng Jung Hsu , Tsong-Hai Lee , Tsung-I Peng . The impact of smoking on the severity of acute ischemic stroke // Journal of the Neurological Sciences. – 2011. –308. – Pp. 94–97

  • Werner F, Jain MK, Feinberg MW et al. Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3 // J Biol Chem. – 2000. – 275. –Pp. 36653-36658

  • White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study // Circulation. – 2005. – Vol. 111. – Pp. 1327 – 1331

  • Wilson A.G., Symons J.A., T.L. McDowell, H.O. McDevitt, G.W. Duff Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation // Proc Natl Acad Sci USA. – 1997. – 94. – Pp. 3195–3199

  • Wolf P. et al. Probability of stroke: a risk profile from the Framingham Study // Stroke. – 1991. – Vol. 22. – Pp. 312 – 318

  • Woods A., Brull D.J., Humphries S.E.,Montgomery H.E. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6 // Eur Heart J. – 2000. – 21(19). – Pp. 1574–83

  • Worrall B.B., Chen D.T., Brown R.D., Brott T.G., and Meschia J.F. A survey of the SWISS researchers on the impact of sibling privacy protections on pedigree recruitment // Neuroepidemiology. – 2005. –Vol. 25, № 1. – Pp. 32–41,

  • Wu Y., Tomon M., Sumino K. Methylenetetrahydrofolate Reductase Gene Polymorphism and Ischemic Stroke: Sex Difference in Japanese // Kobe J. Med. Sci. – 2001. – Vol. 47. – Pp. 255 – 262

  • Xing HY, Liao XP, Xiao F. Haplotypes in the promoter region of β-fibrinogen gene and their relationship with ischemic stroke in the Han population in Hainan // Guo Ji Yi Chuan Xue Za Zhi. – 2006. – 29. – Pp. 328–335

  • Xin XY, Song YY, Ma JF, Fan CN, Ding JQ, Yang GY, Chen SD. Gene polymorphisms and risk of adult early-onset ischemic stroke: A meta-analysis // Thromb Res. – 2009. –Nov,124(5). – Pp. 619-24

  • Xu E, Li W, Zhan L, Guan G, Wang X, Chen S, Shi Y. Polymorphisms of the lipoprotein lipase gene are associated with atherosclerotic cerebral infarction in the Chinese // Neuroscience. – 2008. – 155. – Pp. 403–408

  • Xu X, Li J, Sheng W, Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population // Cerebrovasc Dis. – 2008. –Vol. 26, № 1. – Pp. 48 – 62

  • Yamada Y, Metoki N, Yoshida H, Satoh K, Ichihara S, Kato K, Kameyama T, Yokoi K, Matsuo H, Segawa T, Watanabe S, Nozawa Y. Genetic risk for ischemic and hemorrhagic stroke // Arterioscler Thromb Vasc Biol. – 2006. – 26. – Pp. 1920–1925

  • Yamagami H, Kitagawa K, Nagai Y, Hougaku H, Sakaguchi M, Kuwabara K, Kondo K, Masuyama T, Matsumoto M, Hori M. Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques // Stroke. – 2004. – Mar, 35(3). – Pp. 677-81

  • Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats // Stroke. – 1995. – 26. – Pp. 676–681

  • Yamori Y, Tomimoto K, Ooshima A, Hazama F, Okamoto K: Proceedings: Developmental course of hypertension in the SHR-substrains susceptible to hypertensive cerebrovascular lesions // Jpn Heart J. – 1974. – Mar, 15(2). – Pp. 209-210

  • Yemişçi M, Sinici I, Ozkara HA, Hayran M, Ay H, Celtikçi B, Onder E, Büyükşerbetci G, Kaya EB, Tokgözoglu L, Dalkara T. Protective role of 27bp repeat polymorphism in intron 4 of eNOS gene in lacunar infarction // Free Radic Res. – 2009. – Mar, 43(3). – Pp. 272-279

  • Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese // Circulation. – 2000. – Jun, 20;101(24). – Pp. 2783-7

  • Yoon D., Park S.K., Kang D., Park T., Park J.W. Meta-analysis of homogeneous subgroups reveals association between PDE4D gene variants and ischemic stroke // Neuroepidemiology. – 2011. – 36 (4). – Pp. 213–222

  • Zee R.Y., Cheng S., Hegener H.H. et al. Genetic variants of arachidonate 5lipoxygenaseactivating protein, and risk of incident myocardial infarction and ischemic stroke: a nested casecontrol approach // Stroke. – 2006. –V. 37, № 8. – Pp. 2007–2011

  • Zee R.Y., Cook N.R., Cheng S., Reynolds R., Erlich H.A., Lindpaintner K., Ridker P.M.: Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.// Hum Mol Genet. – 2004. – Feb 15;13(4). – Pp. 389-96

  • Zgang Y. Incidence and risk factors for stroke in American Indians: the Strong Heart Study // Circulation. – 2008. – Vol. 118, № 15. – Pp. 1577 – 1584

  • Zhang J.H., Kohara K., Yamamoto Y., Nakura J., Tabara Y., Fujisawa M., Katagi R., Miki T.: Genetic predisposition to neurological symptoms in lacunar infarction.// Cerebrovasc Dis. – 2004. – 17(4). – Pp. 273-9

  • Zhang Y, Xie RP, Shen Y, Fan DS. Interaction between methylenetetrahydrofolate reductase C677T gene polymorphism and sleep duration on risk of stroke pathogenesis // Beijing Da Xue Xue Bao. – 2008. – 40. – Pp. 262–269

  • Zhao SP, Tong QG, Xiao ZJ, Cheng YC, Zhou HN, Nie S. The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese // Clin Chim Acta. – 2003. – 330. – Pp. 161–164

  • Zhao J, Wang X, Xu J, Li N, Shang X, He Z, Yang J. Association of inflammatory response gene polymorphism with atherothrombotic stroke in Northern Han Chinese // Acta Biochim Biophys Sin (Shanghai). – 2012. – Oct 16

  • Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. – Neurol Res. – 2004. – Dec, 26(8). – Pp. 884-92

  • Zhernakova A., Eerligh P., Barrera P., Wesoly J. Z., Huizinga T. W., Roep B. O., Wijmenga C., and Koeleman B. P., CTLA4 is differentially associated with autoimmune diseases in the Dutch population // Hum Genet. – 2005. – 118(1). – Pp. 58-66

  • Zhou J, Li XX. Association of β-fibrinogen gene –455G/A polymorphism with cerebral infarction // Shen Jing Sun Shang Yu Gong Neng Chong Jian. – 2006. – 1. – Pp. 149–150, – 160

  • Zintzaras, E., Rodopoulou, P. and Sakellaridis, N. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis // Am. J. Epidemiol. – 2009. – 169. – Pp. 523–532

  • www.changbioscience.com/primo

  • http://code.google.com/p/apsampler/

  • http://www.broad.mit.edu/mpg/haploview

  • http://www.graphpad.com/quickcalcs/index.cfm





    Достарыңызбен бөлісу:
  • 1   ...   4   5   6   7   8   9   10   11   12


    ©kzref.org 2019
    әкімшілігінің қараңыз

        Басты бет